Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation.
Transplantation
; 43(6): 870-3, 1987 Jun.
Article
em En
| MEDLINE
| ID: mdl-3296355
ABSTRACT
We determined the incidence of venocclusive disease of the liver (VOD) in 96 recipients of autologous bone marrow transplants (BMT) to be 9.4%, a figure less than that reported for allogeneic transplantation. The development of VOD was compared in a cohort of 21 autologous BMT recipients and in 56 randomly chosen, comparably conditioned, concurrent allogeneic BMT recipients. One of these 21 (4.8%) autologous recipients developed VOD, versus 14 of 56 (25%) allogeneic recipients (P less than 0.05). Logistic regression analysis confirmed pretransplant hepatocellular dysfunction as a risk factor for VOD, and suggested that the use of methotrexate and/or cyclosporine contributes to the development of VOD after chemoradiation therapy. However, a graft-versus-host reaction cannot be excluded as a cause of the higher incidence of VOD in allogeneic recipients.
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Hepatopatia Veno-Oclusiva
/
Transplante de Medula Óssea
Tipo de estudo:
Clinical_trials
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Transplantation
Ano de publicação:
1987
Tipo de documento:
Article